- Q1 2024 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptMay 08, 2024€12.95 (-0.77%)Earnings
- Q4 2023 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptJan 31, 2024€10.6 (-2.75%)Earnings
- Teva Pharmaceutical Industries Ltd at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Q3 2023 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptNov 08, 2023€8.12 (-2.87%)Earnings
- Teva Pharmaceutical Industries Ltd to Discuss the Collaboration with Sanofi to Deliver Inflammatory Bowel Disease Treatment Call TranscriptOct 04, 2023
- Teva Pharmaceutical Industries Ltd at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Q2 2023 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptAug 02, 2023€7.48 (-1.06%)Earnings
- Teva Pharmaceutical Industries Ltd Investor Day TranscriptMay 18, 2023
- Q1 2023 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptMay 10, 2023€8.26 (+0.24%)Earnings
- Teva Pharmaceutical Industries Ltd at Barclays Global Healthcare Conference TranscriptMar 14, 2023
- Q4 2022 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptFeb 08, 2023€9.96 (+0.40%)Earnings
- Teva Pharmaceutical Industries Ltd at JPMorgan Healthcare Conference TranscriptJan 11, 2023
- Q3 2022 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptNov 03, 2022€8.9 (-1.55%)Earnings
- Q2 2022 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptJul 27, 2022€8.06 (+14.81%)Earnings
- Q1 2022 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptMay 03, 2022€8.04 (-2.90%)Earnings
- Q4 2021 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptFeb 09, 2022€7.27 (+0.69%)Earnings
- Teva Pharmaceutical Industries Ltd at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2022
- Q3 2021 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptOct 27, 2021€8.01 (-7.72%)Earnings
- Q2 2021 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptJul 28, 2021€7.51 (-0.40%)Earnings
- Q1 2021 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptApr 28, 2021€8.55 (-1.61%)Earnings
- Teva Pharmaceutical Industries Ltd at JPMorgan Global High Yield & Leveraged Finance Conference (Virtual) TranscriptMar 02, 2021
- Q4 2020 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptFeb 10, 2021€10.54 (+1.74%)Earnings
- Teva Pharmaceutical Industries Ltd at JPMorgan Healthcare Conference (Virtual) TranscriptJan 13, 2021
- Q3 2020 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptNov 05, 2020€7.7 (+1.58%)Earnings
- Q2 2020 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptAug 05, 2020€10.36 (+8.37%)Earnings
- Q1 2020 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptMay 07, 2020€9.75 (+4.17%)Earnings
- Q4 2019 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptFeb 12, 2020€12.12 (+7.07%)Earnings
- Teva Pharmaceutical Industries Ltd at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- Q3 2019 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptNov 07, 2019€7.31 (-2.53%)Earnings
- Q2 2019 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptAug 07, 2019€6.32 (-6.78%)Earnings
- Q1 2019 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptMay 02, 2019€13.55 (-2.87%)Earnings
- Q4 2018 Teva Pharmaceutical Industries Ltd Earnings Call TranscriptFeb 13, 2019€15.1 (-10.44%)Earnings
Teva Pharmaceutical Industries Ltd at JPMorgan Healthcare Conference Transcript
Good morning, everybody. I'm Chris Schott, pharma analyst at JPMorgan. And it's my pleasure to be introducing Teva today.
From the company we have CEO, Richard Francis. Richard joined Teva roughly a year ago. The company has had a very productive 2023 and looking forward to hearing about the setup for Teva going forward.
So with that, Richard, thanks for joining us. And we'll jump to Q&A after your presentation.
Thanks very much, Chris. Good morning, everybody. Delighted to be here. Yes, it's been One year, one hell of a year, where I think that the work we've done at Teva has really transformed Teva, quite a bit of change and put us on the path for continuous growth going forward. So very excited about that.
And let me walk you through a bit of what's given me that optimism and some of the progress we've made in that first year. So when I was here last
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)